Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0450
+0.0100 (28.57%)
Nov 10, 2025, 9:38 AM EST
Enzon Pharmaceuticals Revenue
In the year 2024, Enzon Pharmaceuticals had annual revenue of $26.00K.
Revenue
26.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
3.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 26.00K | -675.00K | -96.29% |
| Dec 31, 2021 | 701.00K | 649.00K | 1,248.08% |
| Dec 31, 2020 | 52.00K | -155.00K | -74.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Mid-Atlantic Home Health Network | 27.00M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
Enzon Pharmaceuticals News
- 16 days ago - Enzon and Viskase Announce Amendment to Merger Agreement - GlobeNewsWire
- 5 months ago - Enzon and Viskase Enter into Merger Agreement - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals Announces Results of Rights Offering - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals Announces Key Dates for Rights Offering - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders - GlobeNewsWire
- 5 years ago - Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value - GlobeNewsWire